Long-term benefits of TUMT (transurethral microwave thermotherapy) unproven, says Swedish council
This article was originally published in Clinica
Executive Summary
Although scientific documentation for the short-term effects of high energy transurethral microwave thermotherapy (TUMT) in the treatment of benign prostate hypertrophy (BPH) exists, few studies have been carried out on long-term benefits to patients, claims a new report by the Swedish council on technology assessment in health care (SBU). In addition to this, there has been no cost analysis of high energy TUMT in comparison with other treatment methods, says SBU in an alert issued last week.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.